Promaxo Holdings, Inc.
Biotechnology · OAKLAND, CA
BiotechnologySEC Form D
Promaxo Holdings, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 30, 2026, reporting $26,848,795 raised toward a $28,781,164 offering.
Incorporated in Delaware and based in OAKLAND, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Promaxo Holdings, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Amit VohraExecutive Officer · Director
- Michael BartholomewExecutive Officer
- Dushyant ChipalkattyDirector
- Derek HenneckeDirector
- Srirama VenkataramanExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised